hydro research semaglutide GLP-1 Receptor Agonist Reference hydro research semaglutide Semaglutide Injection

Bottom line The essence of microdosing semaglutide is to find the most effective, lowest dose for you, minimize side effects, and achieve lasting metabolic improvements

Wegovys most common side effects were gastrointestinal problems, including nausea, diarrhea and vomiting

Semaglutide is a Glucagon-like Peptide-1 Agonist that stimulates the GLP-1 receptors in our body

Weekly Dosing Both are generally administered once weekly with gradual dose escalation

Tirzepatide, a newer medication, combines GLP-1 and GIP receptor agonists, which have a more potent effect on weight loss, with research showing it may lead to greater reductions in body weight compared to Semaglutide